New York Times: They Shunned Covid Vaccines but Embraced Antibody Treatment

New York Times: They Shunned Covid Vaccines but Embraced Antibody Treatment. “Vaccine-resistant Americans are turning to the treatment with a zeal that has, at times, mystified their doctors, chasing down lengthy infusions after rejecting vaccines that cost one-hundredth as much. Orders have exploded so quickly this summer — to 168,000 doses per week in late August, up from 27,000 in July — that the Biden administration warned states this week of a dwindling national supply.”

Washington Post: Biden administration moves to stave off shortage of monoclonal antibodies

Washington Post: Biden administration moves to stave off shortage of monoclonal antibodies. “The Biden administration moved this week to stave off a shortage of monoclonal antibodies, taking over distribution of the critical covid-19 therapy while it tries to purchase more. The policy change that went into effect Monday is all but certain to result in cuts of the medication to some states, especially seven in the Deep South with high infection rates that have been using about 70 percent of the national supply.”

WJCT: COVID Antibody Treatments Get Underway At Jacksonville’s Main Library

WJCT: COVID Antibody Treatments Get Underway At Jacksonville’s Main Library. “The Regeneron monoclonal antibody treatment site at the Downtown Jacksonville Main Library opened Tuesday morning, offering a COVID-19 treatment option with no doctor referral needed. Monoclonal antibodies are a treatment authorized by the U.S. Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA) for use in adult and pediatric patients (12 and older). ”

CNN: US government stops distribution of Eli Lilly Covid-19 antibody treatment due to spread of coronavirus variants

CNN: US government stops distribution of Eli Lilly Covid-19 antibody treatment due to spread of coronavirus variants. “The US government in coordination with Eli Lilly said it will no longer distribute the Covid-19 monoclonal antibody therapy bamlanivimab for use on its own. The halt is due to the ‘sustained increase’ in coronavirus variants in the United States.”

Politico: Game-changing coronavirus medicine gears up for production

Politico: Game-changing coronavirus medicine gears up for production. “Amid alarming spikes in infections and a wave of new restrictions announced across Europe, some good news is emerging: Monoclonal antibodies are likely to be the first game-changing therapy against COVID-19. Big drugmakers have ample experience in manufacturing these kinds of medicines, and their existing facilities can readily be converted to produce doses of a future COVID-19 treatment, experts say.”